Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Jan 21, 2010 shooter eric m Director Option Execute 15,000 15.80
Feb 17, 2010 shooter eric m Director Automatic Sell 15,000 30.00
Feb 17, 2010 shooter eric m Director Option Execute 15,000 18.80
May 13, 2010 shooter eric m Director Option Execute 5,000 25.43
Nov 23, 2010 shooter eric m Director Automatic Sell 7,500 30.00
Nov 13, 2009 sing george l Director Buy 10,000 18.78
Nov 13, 2009 sing george l Director Buy 2,500 18.68 - 18.72
May 18, 2010 sing george l Director Buy 5,000 28.44
May 18, 2010 sing george l Director Buy 2,500 28.64
Jun 9, 2010 sing george l Director Option Execute 5,000 25.43
Nov 22, 2011 sing george l Director Option Execute 15,000 28.81
Feb 14, 2014 sing george l Director Option Execute 15,000 9.17
Feb 21, 2014 sing george l Director Sell 15,000 338.00 - 340.00
Feb 21, 2014 sing george l Director Option Execute 15,000 15.80
Feb 20, 2015 sing george l Director Sell 15,000 423.12
Feb 20, 2015 sing george l Director Option Execute 15,000 18.61
Dec 17, 2012 sing george l Director Acquisition (Non Open Market) 10,000 n/a
May 10, 2013 sing george l Director Sell 5,000 270.00
May 10, 2013 sing george l Director Option Execute 5,000 15.01
Nov 26, 2013 sing george l Director Sell 10,000 295.00
Showing 301-320 of 933 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)